Matrix-Degrading Enzyme Expression and Aortic Fibrosis During Continuous-Flow Left Ventricular Mechanical Support
- 1 November 2021
- Vol. 78 (18) , 1782-1795
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencingScientific Reports, 2016
- Restoration of Pulsatile Flow Reduces Sympathetic Nerve Activity Among Individuals With Continuous-Flow Left Ventricular Assist DevicesCirculation, 2015
- Changes in Aortic Wall Structure, Composition, and Stiffness With Continuous-Flow Left Ventricular Assist DevicesCirculation: Heart Failure, 2015
- Targeting cardiac fibroblasts to treat fibrosis of the heart: Focus on HDACsJournal of Molecular and Cellular Cardiology, 2014
- Neurohormonal Regulation and Improvement in Blood Glucose Control: Reduction of Insulin Requirement in Patients with a Nonpulsatile Ventricular Assist DeviceThe Heart Surgery Forum, 2014
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Second harmonic generation microscopy for quantitative analysis of collagen fibrillar structureNature Protocols, 2012
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling processProgress in Biophysics and Molecular Biology, 2008
- Pulsatile and Nonpulsatile Blood FlowJAMA, 1965